Antibody responses to an immunodominant nonstructural 1 synthetic peptide in patients with dengue fever and dengue hemorrhagic fever

Journal of Medical Virology

Volumn 57, Issue 1, 1999, Pages 1-8

  Huang, Jyh Hsiung ^a   Wey, Jiunn Jye ^b   Sun, Yu Chen ^a   Chin, Chuan ^a,b   Chien, Li Jung ^a   Wu, Ying Chang ^a  

^a DEPARTMENT OF HEALTH   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Dengue; Nonstructural 1; Synthetic peptide

Indexed keywords

EPITOPE; IMMUNOGLOBULIN M; PEPTIDE ANTIBODY; SYNTHETIC PEPTIDE;

ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; DENGUE; DENGUE VIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; HUMAN; JAPANESE ENCEPHALITIS VIRUS; MOUSE; NEWBORN; NONHUMAN; SEROLOGY;

AMINO ACID SEQUENCE; ANIMALS; ANIMALS, SUCKLING; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; B-LYMPHOCYTES; CELL LINE; CONVALESCENCE; DENGUE; DENGUE HEMORRHAGIC FEVER; DENGUE VIRUS; ENCEPHALITIS, JAPANESE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNODOMINANT EPITOPES; IMMUNOGLOBULIN M; MICE; MOLECULAR SEQUENCE DATA; PEPTIDE BIOSYNTHESIS; VACCINES, SYNTHETIC; VIRAL NONSTRUCTURAL PROTEINS;

ANIMALIA; DENGUE VIRUS; JAPANESE ENCEPHALITIS VIRUS; RNA VIRUSES;

EID: 0032889977     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199901)57:1<1::AID-JMV1>3.0.CO;2-T     Document Type: Article

References (36)

1. Bhamarapravati N. 1989. Hemostatic defects in dengue hemorrhagic fever. J Infect Dis 4(Suppl.):S826-S829.
2. Bravo JR, Guzman MG, Kouri GP. 1987. Why dengue haemorrhagic fever in Cuba? I. Individual risk factors for dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS). Trans R Soc Trop Med Hygiene 81:816-820.
3. Burke DS, Nisalak A, Johnson DE, Scott RM. 1988. A prospective study of dengue infections in Bangkok. Am J Trop Med Hygiene 38:172-180.
4. Churdboonchart V, Bhamarapravati N, Peampramprecha S, Sirinavin S. 1991. Antibodies against dengue viral proteins in primary and secondary dengue hemorrhagic fever. Am J Trop Med Hygiene 44:481-493.
5. Clarke DH, Casals J. 1958. Techniques for hemagglutination and hemagglutination inhibition with arthropod-borne virus. Am J Trop Med Hygiene 7:561-577.
6. Deubel V, Kinney RM, Trent DW. 1986. Nucleotide sequence and deduced amino acid sequence of the structural proteins of dengue type 2 virus, Jamaica genotype. Virology 155:365-377.
7. Falconar AK. 1997. The dengue virus nonstructural-1 protein (NS1) generates antibodies to common epitopes on human blood clotting, integrin/adhesin proteins and binds to human endothelial cells: potential implications in haemorrhagic fever pathogenesis. Arch Virol 142:897-916.
8. Falgout B, Bray M, Schlesinger JJ, Lai CJ. 1990. Immunization of mice with recombinant vaccinia virus expressing authentic dengue virus nonstructural protein NS1 protects against lethal dengue virus encephalitis. J Virol 64:4356-4363.
9. Falkler WA, Diwan AR, Halstead SB. 1973. Human antibody to dengue soluble complement-fixing (SCF) antigens. J Immunol 111: 1804-1809.
10. Gubler DJ. 1997. Dengue and dengue hemorrhagic fever: its history and resurgence as a global public health problem. In Gubler DJ, Kuno G, editors. Dengue and dengue hemorrhagic fever. New York: CAB International, p 1-22.
11. Gubler DJ, Reed D, Rosen L, Hitchcock JCJ. 1978. Epidemiologic, clinical, and virologic observations on dengue in the kingdom of Tonga. Am J Trop Med Hygiene 27:581-589.
12. Halstead SB. 1970. Observations related to pathogenesis of dengue hemorrhagic fever. VI. Hypotheses and discussion. Yale J Biol Med 42:350-362.
13. Halstead SB. 1979. In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. J Infect Dis 140:527-533.
14. Halstead SB, O'Rourke EJ. 1977. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J Exp Med 146:201-217.
15. Halstead SB, Shotwell H, Casals J. 1973. Studies on the pathogenesis of dengue infection in monkeys II. Clinical laboratory responses to heterologous infection. J Infect Dis 128:15-22.
16. Henchal EA, McCown JM, Burke DS, Seguin MC, Brandt WE. 1985. Epitopic analysis of antigenic determinants on the surface of dengue-2 virus using monoclonal antibodies. Am J Trop Med Hygiene 34:162-169.
17. Henchal EA, Henchal LS, Schlesinger JJ. 1988. Synergistic interactions of anti-NS1 monoclonal antibodies protect passively immunized mice from lethal challenge with dengue 2 virus. J Gen Virol 69:2101-2107.
18. Huang JH, Wey JJ, Lee HF, Tsou TL, Wu CS, Wu JR, Chen HM, Chin C, Chien LJ, Chen LK, Wu YC, Pan MJ, Wang TM. 1996. Identification of immunodominant, group-specific and subcomplex-specific, continuous epitopes in the core regions of Japanese encephalitis virus using synthetic peptides. Virus Res 41:43-53.
19. Kuno G, Vorndam AV, Gubler DJ, Gomez I. 1990. Study of anti-dengue NS1 antibody by Western blot. J Med Virol 32:102-108.
20. Lanciotti, RS, Calisher, CH, Gubler DJ, Chang GJ, Vorndam AV. 1992. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol 30:545-551.
21. Mady BJ, Kurane I, Erbe DV, Fanger MW, Ennis FA. 1993. Neuraminidase augments Fc receptor II-mediated antibody-dependent enhancement of dengue virus infection. J Gen Virol 74:839-844.
22. Mason PW, McAda PC, Mason TL, Fournier MJ. 1987. Sequence of the dengue-1 virus genome in the region encoding the three structural proteins and the major nonstructural protein NS1. Virology 161:262-267.
23. Monath TP, Nystrom RR, Bailey RE, Calisher CH, Muth DJ. 1984. Immunoglobulin M antibody capture enzyme-linked immunosorbent assay for diagnosis of St. Louis encephalitis. J Clin Microbiol 20:784-790.
24. Nimmannitya S. 1987. Clinical spectrum and management of dengue haemorrhagic fever. Southeast Asian J Trop Med Public Health 18:392-397.
25. Nimmannitya S, Halstead SB, Cohen SN, Margiotta MR. 1969. Dengue and Chikungunya virus infection in man in Thailand, 1962-1964. I. Observations on hospitalized patients with haemorrhagic fever. Am J Trop Med Hygiene 18:954-971.
26. Osatomi K, Sumiyoshi H. 1990. Complete nucleotide sequence of dengue type 3 virus genome RNA. Virology 176:643-647.
27. Qu X, Chen W, Maguire T, Austin F. 1993. Immunoreactivity and protective effects in mice of a recombinant dengue 2 Tonga virus NS1 protein produced in baculovirus expression system. J Gen Virol 74:89-97.
28. Rosen L. 1977. The Emperor's New Clothes revisited, or reflections on the pathogenesis of dengue hemorrhagic fever. Am J Trop Med Hygiene 26:337-343.
29. Russell PK, Nisalak A, Sukhavachana P, Vivona S. 1967. A plaque reduction test for dengue virus neutralizing antibodies. J Immunol 99:285-290.
30. Sangkawibha N, Rojanasuphot S, Ahandrik S, Viriyapongse S, Jatanasen S, Salitul V, Phanthumachinda B, Halstead SB. 1984. Risk factors for dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am J Epidemiol 120:653-669.
31. Schlesinger JJ, Brandriss MW, Walsh EE. 1987. Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1. J Gen Virol 68: 853-857.
32. Sumiyoshi H, Mori C, Fuke I, Morita K, Kuhara S, Kondou J, Kikuchi Y, Nagamatu H, Igarashi A. 1987. Complete nucleotide sequence of the Japanese encephalitis virus genome RNA. Virology 161: 497-510.
33. Tan CHC, Yap EH, Singh M, Deubel V, Chan YC. 1990. Passive protection studies in mice with monoclonal antibodies directed against the non-structural protein NS3 of dengue 1 virus. J Gen Virol 71:745-748.
34. World Health Organization. 1986. Dengue haemorrhagic fever: diagnosis, treatment and control. Geneva: World Health Organization.
35. World Health Organization. 1994. Dengue haemorrhagic fever: diagnosis, treatment and control. Geneva: World Health Organization.
36. Zhao B, Mackow E, Buckler-White A, Markoff L, Chanock RM, Lai CJ, Makino Y. 1986. Cloning full-length dengue type 4 DNA sequences: analysis of genes coding for structural proteins. Virology 155:77-88.